Sales Growth YoY (Last 12 Months): intensitytherapeutics.com (INTS)

Intensity Therapeutics minimizes oncological risks by developing injection methods directly into neoplasms. This chart of trailing 12-month year-over-year revenue growth demonstrates the impact of this strategy, where the metric is recorded at 0.00. Synergy with pharma behemoths and the acquisition of patents support development, although costs for final tests create financial pressure and a dependence on external funding.
Intensity Therapeutics (INTS) - metric breakdowns and financial figures

Intensity Therapeutics focuses on developing the high-tech DATH platform for targeted oncology therapy. This indicator captures the percentage change in revenue over the last 12 months relative to the same preceding period. The metric allows for an assessment of the commercial scalability of R&D projects and the pace of innovation monetization. A stable trend confirms market demand for the company's developments. By analyzing the relative sales growth over a 12-month period compared to the previous year, an investor determines the stage of business development.